Assoc. Prof. Dr. Zehra Beştepe Dursun

2002–2008 — Faculté de médecine de l’Université Erciyes

2009–2015 — Hôpital de formation et de recherche de Kayseri, Université des sciences de la santé — spécialisation en maladies infectieuses et microbiologie clinique

2008–2009 — Hôpital public de Yahyalı — médecin généraliste

2015–2018 — Hôpital de formation et de recherche de Kayseri — spécialiste

2018–2023 — Hôpital municipal de formation et de recherche de Kayseri — spécialiste

2023–2024 — Hôpital municipal de formation et de recherche de Kayseri — maître de conférences

Liv Hospital Bahçeşehir

Faculté de médecine de l’Université Istinye

Maladies infectieuses

Microbiologie clinique

Infections associées aux soins

Infections virales et COVID-19

Hépatites chroniques

Vaccination et immunisation des adultes

Maladies fébriles

Traitements antimicrobiens et bon usage des antibiotiques

30.04.2020–30.04.2021 — Projet de développement d’un vaccin contre la COVID-19, TÜSEB — chercheuse, projet national.

Risk factors and lethality associated with Candidemia in severe COVID-19 patients , 2022

COVID-19: vaccination vs. hospitalization , 2022

Nutritional Risk, Micronutrient Status and Clinical Outcomes: A Prospective Observational Study in an Infectious Disease Clinic , 2016

The Relationship Between Cytokine Concentrations and Severity Scoring Index for Crimean-Congo Hemorrhagic Fever, 2023

Efficacy of therapeutic plasma exchange in patients with Crimean-Congo hemorrhagic fever, 2021

Confronting a Pandemic in Early Stages: A Retrospective Analysis From a Pandemic Hospital, 2020

İÇ ANADOLU BÖLGESİNDE CANDİDALARIN NEDEN OLDUĞU OTOMİKOZLAR VE ANTİFUNGAL DUYARLILIKLARI, 2019

Retrospective analysis on efficacy of convalescent plasma in acute respiratory distress syndrome due to COVID-19, 2022

Does serum butyrylcholinesterase level determine the severity and mortality of COVID-19 pneumonia?: Prospective study, 2022

RİNOORBİTAL MUKORMİKOZİSLİ HASTALARDA TEDAVİ YAKLAŞIMIMIZ , 2017

Covid-19 Salgını Sırasında Sağlık Çalışanlarında Anksiyete ve Depresyon Düzeyi, Sosyodemografik Özelliklerle İlişkisi, 2022

New onset atrial fibrilation and risk faktors in COVID-19, 2021

Microorganisms Caused of Bacteremia in the Intensive Care Unit and Their Antibiotic Susceptibilities, 2019

The epidemiology and antifungal susceptibility of Candida species isolated from patients in intensive care units of a research hospital, 2022

Evaluation of the Crimean-Congo Hemorrhagic Fever Cases Followed and Treated in Our Clinic between 2009-2013, 2016

Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience, 2020

Fungal profile and antifungal susceptibility pattern in patients with oral candidiasis, 2022

Epidemiology and Clinical Features of Seasonal Influenza Cases Followed in Our Clinic, 2018

Telaprevir-based triple therapy for re-treatment Chronic HCV patients with Genotype 1, including the Null-Response: A single center experience from Turkey, 2017

An unusual cause for fever of unknown origin: Pulmonary arterial aneurysm, 2021

Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey, 2020

A case of splenic infarction associated with brucellosis which resolved with antimicrobial treatment, 2012

Usefulness of C-reactive protein/albumin ratio as a predictor of new-onset atrial fibrillation in SARS-COV-2, 2021

Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies, 2020

Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey, 2017

A fatal invasive Scedosporium apiospermum pulmonary infection in an adult patient with malignant lung adenocarcinoma, 2020

Effect of Various Disinfectants Used, on Resistant Bacteria in Our Hospital, 2021

Evaluation of the tularemia cases admitted to our hospital between 2010 and 2013 from the provinces of Central Anatolia, 2015

COVID-19 among Turkish citizens returning from abroad, 2020

Telaprevir-based Triple Therapy for Retreatment of Chronic Hepatitis C Patients with Genotype Four Followed in Our Clinic, 2016

Evaluation of major and minor lower extremity amputation in diabetic foot patients, 2017

Kronik hepatit B hastalarında potent antiviral tedavinin değerlendirilmesi, 2020

ORTOPEDİ KLİNİĞİNDE UYGULANAN ELEKTİF KALÇA VE DİZ PROTEZİ OPERASYONLARINDA CERRAHİ PROFİLAKSİYE UYUM - BAHADIR FATMA, KÜRKLÜ BOZKIR FİLİZ, BEŞTEPE DURSUN ZEHRA, AKYÜREK TUĞBA, KAYA FÜRUZAN, Demirel Güğül Tuğba, İNANICI BERNA, ÇELİK İLHAMİ

Sitokin Seviyeleri İle COVID-19’un Şiddeti Arasındaki İlişki - BEŞTEPE DURSUN ZEHRA, SAATÇİ ESMA, ÇELİK İLHAMİ

Kronik Hepatit B Hastalarında Potent Antiviral Tedavinin Değerlendirilmesi - BEŞTEPE DURSUN ZEHRA, ÇELİK İLHAMİ

Kronik Hepatit C Hastalarında Paritaprevir/Ritonavir/ Ombitasvir + Dasabuvir ve Sofosbuvir/Ledipasvir Tedavilerinin Etkiniği, Güvenilirliği ve Klinik Sonuçlarının Değerlendirilmesi - Demirel Güğül Tuğba, ÇELİK İLHAMİ, TÜRE YÜCE ZEYNEP, BEŞTEPE DURSUN ZEHRA, TURUNÇ ÖZDEMİR AYŞE, İNANICI BERNA

Yoğun Bakım Ünitesinde Karbapenem Kullanımı Kısıtlamasının Çok İlaca Dirençli Gram-olumsuz Bakterilere Bağlı Hastane Enfeksiyonu Hızına Etkisi - TÜRE YÜCE ZEYNEP, ÇELİK İLHAMİ, ÖZ GÖKŞEN, ÇETİN ŞERİFE, Demirel Güğül Tuğba, AYDIN SALİHA, BEŞTEPE DURSUN ZEHRA

KIRIM-KONGO KANAMALI ATEŞİ HASTALIĞINDA PLAZMA EXCHANGE TEDAVİSİNİN RÖLÜ - HASIRCI BURAK, SARIKOÇ MURAT, AKDENİZ MUSTAFA, BEŞTEPE DURSUN ZEHRA, KORKMAZ EMİNE, ÇELİK İLHAMİ, ATA NAİM, KORKMAZ SERDAL

HIV Patients During the COVID-19 Pandemic - BEŞTEPE DURSUN ZEHRA

65 YAŞ ÜSTÜ HASTALARDA PNOMOKOK AŞISI BILGI DÜZEYI VE AŞILANMA DURUMLARI - BEŞTEPE DURSUN ZEHRA, ORTAKÖYLÜOĞLU ADİLE

Koruyucu Sağlık Ansiklopedisi, 2012 – Türk Eczacılar Birliği

Paramedik, 2020 – akademisyen